Loading clinical trials...
Loading clinical trials...
Primary objective of this open label, two-arm, multicenter, multinational, randomized trial is to compare anti-leukemic activity of allogeneic stem cell transplantation for patients with acute leukemi...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Universitätsklinikum Hamburg-Eppendorf
Collaborators
NCT02269592 · Monoclonal Gammopathy of Undetermined Significance (MGUS), Myelodysplastic Syndromes, and more
NCT06303193 · Myelodysplastic Syndromes
NCT06847867 · Myelodysplastic Syndromes
NCT06439199 · Acute Myeloid Leukemia, Myelodysplastic Syndromes, and more
NCT07216443 · Leukemia, Myeloid, Acute, Myelodysplastic Syndromes, and more
LKH-Univ. Klinikum Graz
Graz
Medizinische Universität Innsbruck
Innsbruck
Medizinische Universität Wien, Universitätsklinik für Innere Medizin I Einrichtung für Stammzelltransplantation KMT
Vienna
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions